Noiret, Barbara
Piessen, Guillaume
Eveno, Clarisse
Article History
Received: 26 April 2024
Accepted: 28 April 2024
First Online: 18 May 2024
Disclosures
: Guillaume Piessen has undertaken consulting work for BMS, Nestlé, Astellas Pharma, MSD, and Daiichi; is a member of the Advisory Board for BMS; and has received travel and accommodation expenses from Medtronic and MSD. Barbara Noiret and Clarisse Eveno have no disclosures to declare that may be relevant to the contents of this manuscript.